Emerging Technologies

The industry is better off viewing the the floundering deals between Onduo and Sanofi, Proteus and Otsuka, and Pear and Sandoz as a learning opportunity.

CEO and President Dr. Corey McCann said that Somryst, a digital treatment for chronic insomnia and depression, is the first software as a medical device product to be submitted through the regulator's pilot pathway. 

The country's FinnGen Project seeks to use its unique population bottleneck and cohesive health records to drive genetic insights.

From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.

The companies will be using DEARhealth's platform, which integrates AI into EHRs to predict health outcomes. 

How to build a long-term culture of sustainable innovation.